O. Bauduceau
Papers
2
Total Citations
48
H-Index
2
About
Dr. O. Bauduceau is a leading figure in the advancement of robotic stereotactic body radiation therapy (SBRT), with a particular focus on integrating precision technologies to improve cancer treatment outcomes. Their research primarily centers on the clinical and economic evaluation of robotic-assisted radiotherapy, especially for extracranial and prostate cancers. A key contribution is their seminal work on the safety and efficacy of fiducial marker implantation for CyberKnife® SBRT, a study that has garnered 41 citations and established essential protocols for real-time tumor tracking. This foundational research has directly enhanced the precision and reduced the toxicity of stereotactic treatments. Dr. Bauduceau has also made significant strides in health economics, notably through a 2022 cost-utility analysis comparing robot-assisted surgery to robotic SBRT for prostate cancer. This work provides critical insights into the value-based allocation of advanced oncological resources. By bridging technical feasibility with economic sustainability, Dr. Bauduceau’s research continues to shape clinical guidelines and inform decision-making for both practitioners and healthcare systems.
Research Focus
Key Achievements
Top Papers
- 1
- 2